摘要:
5-membered heterocyclic derivatives represented by general formula (I) having xanthine oxidase inhibitory activities and useful as agents for the prevention or treatment of a disease associated with abnormality of serum uric acid level, prodrugs thereof, or salts thereof. In the formula (I), T represents nitro, cyano and the like; ring J represents aryl or heteroaryl; Q represents carboxy, 5-tetazolyl and the like; Y represents H, OH, NH2, halogen, haloalkyl and the like; X1 and X2 independently represent CR2 or N; R2 represents H, alkyl and the like; R1 represents halogen, cyano, haloalkyl, A-D-E-G-L-M, —N(-D-L-M)2 and the like, A represents a single bond, O, S and the like; D, G and M independently represent optionally substituted alkylene, cycloalkylene, heterocycloalkylene, arylene, heteroarylene and the like; E and L independently represent a single bond, O, S, COO, SO2 and the like.
摘要:
An automatic focus camera Unit 10, comprises; a piezoelectric element 13a; a driving shaft 13b to be driven by the piezoelectric element 13a; a moving unit 13c to be moved with respect to the driving shaft 13b by a friction force caused by the driving shaft 13b; a microcomputer unit 24 for controlling power supply to the piezoelectric element 13a, and in which the microcomputer unit 24 assumes a preprocessing mode of calculating an amount of adjustment for a power supply time in accordance with a moving direction of the moving unit 13c, and a movement controlling mode of adjusting the supply time and controlling power supply based on the moving direction and the amount of adjustment. In the preprocessing mode, the moving unit 13c is controlled based on the detecting result of the base end sensor 15 and moved in forward and backward directions using the base end position 15a as a reference point, and the amount of adjustment is calculated based on the supply time for which power is supplied while the moving unit 13c is moved in the forward direction and the supply time for which power is supplied while the moving unit 13c is moved in backward direction.
摘要:
The present invention provides compounds useful as agents for the prevention or treatment of a disease associated with abnormal serum uric acid level which has a uricosuric activity or the like. The present invention relates to (aza)indole derivatives represented by the following general formula (I) having xanthine oxidase inhibitory activities and useful as agents for the prevention or treatment of a disease associated with abnormality of serum uric acid level, prodrugs thereof, or salts thereof. In the formula (I), T represents nitro or cyano and the like; ring J represents aryl or heteroaryl and the like; Q represents carboxy or 5-tetazolyl and the like; Y represents H, OH, NH2, halogen, nitro, alkyl, alkoxy and the like; X1, X2 and X3 independently represent CR2 or N; R1 and R2 independently represent halogen, cyano, haloalkyl, A-D-E-G, —N(-D-E-G)2 and the like, in the formula, A represents a single bond, O, S and the like; D and G independently represent optionally substituted alkylene, cycloalkylene, heterocycloalkylene, arylene, heteroarylene and the like; E represents a single bond, O, S, COO, SO2 and the like.
摘要:
The present invention provides pyrazole derivatives represented by the general formula: wherein R1 represents H, an optionally substituted C1-6 alkyl group etc.; one of Q and T represents a group selected from the following groups: , and the other represents —(CH2)n—Ar wherein Ar represents an optionally substituted C6-10 aryl group or an optionally substituted C1-9 heteroaryl group; and n represents an integral number from 0 to 2, an optionally substituted C1-6 alkoxyl group, an optionally substituted amino group, an optionally substituted C2-9 heterocycloalkyl group or an optionally substituted heterocycle-fused phenyl group; R represents an optionally substituted C3-8 cycloalkyl group, an optionally substituted C6-10 aryl group etc., pharmaceutically acceptable salts thereof or prodrugs thereof, which exhibit an excellent inhibitory activity in human 1,5-anhydroglucitol/fructose/mannose transporter and are useful as agents for the prevention, inhibition of progression or treatment of a disease associated with the excess uptake of at least a kind of carbohydrates selected from glucose, fructose and mannose or a disease associated with hyperglycemia (e.g., diabetic complications, diabetes, etc.), and pharmaceutical compositions comprising the same, pharmaceutical uses thereof, and intermediates for production thereof.
摘要:
The present invention provides benzimidazole derivatives represented by the following formula (I) or pharmaceutically acceptable salts thereof, or prodrugs thereof, which exert an inhibitory activity on sodium-dependent nucleoside transporter 2 and are useful for a disease associated with an abnormality of plasma uric acid level. The compounds of the present invention are useful for the prevention or treatment of gout, hyperuricemia, urinary lithiasis, hyperuricemic nephropathy or the like.In the formula, n is 1 or 2; R1 and R2 are H, a halogen atom, cyano group, optionally substituted alkyl group, optionally substituted aryl group or the like; R3 is H, a halogen atom, optionally substituted alkyl group or the like; R4 and R5 are H, a halogen atom, OH or the like; and R6 and RX are H or OH: RY is F or OH.
摘要翻译:本发明提供由下式(I)表示的苯并咪唑衍生物或其药学上可接受的盐或其前药,其对钠依赖性核苷转运蛋白2具有抑制活性,并且可用于与血浆尿酸异常有关的疾病 水平。 本发明的化合物可用于预防或治疗痛风,高尿酸血症,尿结石病,高尿酸性肾病等。 在该式中,n为1或2; R 1和R 2是H,卤素原子,氰基,任选取代的烷基,任选取代的芳基等; R3是H,卤素原子,任选取代的烷基等; R 4和R 5是H,卤素原子,OH等; R6和RX是H或OH:RY是F或OH。
摘要:
[Problems] It is therefore an object of the present invention to provide a driving apparatus which can be reduced in the number of complete parts in comparison with the conventional driving apparatus.[Means for Solving Problems] An automatic focus camera unit 10, comprises; a piezoelectric element 13a; a driving shaft 13b to be driven by the piezoelectric element 13a; a moving unit 13c to be moved with respect to the driving shaft 13b by a friction force caused by the driving shaft 13b; a microcomputer unit 24 for controlling power supply to the piezoelectric element 13a, and in which the microcomputer unit 24 assumes a preprocessing mode of calculating an amount of adjustment for a power supply time in accordance with a moving direction of the moving unit 13c, and a movement controlling mode of adjusting the supply time and controlling power supply based on the moving direction and the amount of adjustment. In the preprocessing mode, the moving unit 13c is controlled based on the detecting result of the base end sensor 15 and moved in forward and backward directions using the base end position 15a as a reference point, and the amount of adjustment is calculated based on the supply time for which power is supplied while the moving unit 13c is moved in the forward direction and the supply time for which power is supplied while the moving unit 13c is moved in backward direction.
摘要:
The present invention provides pyrazole derivatives represented by the general formula: wherein R1 represents H, an optionally substituted C1-6 alkyl, etc.; one of Q and T represents a group selected from the following: , and the other represents -Z-Ar wherein Z represents —O—, —S—, etc.; Ar represents an optionally substituted C6-10 aryl, etc.; R represents an optionally substituted C3-8 cycloalkyl, an optionally substituted C6-10 aryl, etc., pharmaceutically acceptable salts thereof, and prodrugs thereof, which exhibit an excellent inhibitory activity in human sodium/glucose cotransporter (SGLT) and are useful as agents for the prevention, inhibition of progression or treatment of a disease associated with the excess uptake of at least a kind of carbohydrates selected from glucose, fructose and mannose (diabetes, postprandial hyperglycemia, impaired glucose tolerance, diabetic complications, etc.), and pharmaceutical compositions containing the same, medicinal uses thereof and intermediates for production therefor.
摘要:
A method and an apparatus for machining a mold material to produce a mold. By casting based on a cast mold model (15), a mold material (20) is produced in a form having a work margin. Thereafter, a shape of the mold material (20) is measured by a measuring device (16), and measurement data and an envelope model (M2) generated based on the measurement data are stored in a storage unit (12A) of a computer (12). Thereafter, a mold model (M1) based on mold design data and an envelope model (M2) are displayed on a display unit (12C), and the envelope model (M2) is linearly moved in direction of three axes X, Y and Z orthogonal to one another respectively and rotated around the three axes to bring a product forming plane (M2B) of the envelope model (M2) into close proximity of a product forming plane (M1B) of the mold model (M1). Thereby, a state in which a work amount of a product forming plane (20B) of the mold material (20) is reduced is found, and a reference plane (20A) and a product forming plane (20B) of the mold material 20 are cut by a mold working machine (18) controlled by the computer (12).